Askleia is developing a breakthrough technology for the purification of biotechnology-derived products. Our innovation is based, in particular, on continuous-flow electrophoresis.
How does this technology differ from current purification methods?
Conventional chromatography relies on stationary phases that require regular regeneration and replacement. Askleia's continuous-flow electrophoresis technology eliminates the need for any stationary phase. Instead, molecules flow continuously through the system while being separated by an electric field, enabling a continuous and efficient purification process.
